Stride Arcolab’s arm receives US FDA approval for Ifosfamide Injection

29 Nov 2012 Evaluate

Onco Therapies, a wholly owned subsidiary of Stride Arcolab has received ANDA approval for Ifosfamide Injection 50 mg/ mL packaged in 1 gram / 20 mL and 3 grams / 60 mL Single – dose vials.

Ifosfamide is part of the Oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.

According to IMS data, the US market for generic Ifosfamide is approximately $15 Million.

Strides Pharma Scien Share Price

865.05 14.40 (1.69%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×